Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2010

01-12-2010 | Original Article

Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance

Authors: Erin M. Coffee, Dean R. Tolan

Published in: Journal of Inherited Metabolic Disease | Issue 6/2010

Login to get access

Abstract

Hereditary fructose intolerance (HFI) is a potentially fatal inherited metabolic disease caused by a deficiency of aldolase B activity in the liver and kidney. Over 40 disease-causing mutations are known in the protein-coding region of ALDOB. Mutations upstream of the protein-coding portion of ALDOB are reported here for the first time. DNA sequence analysis of 61 HFI patients revealed single base mutations in the promoter, intronic enhancer, and the first exon, which is entirely untranslated. One mutation, g.−132G>A, is located within the promoter at an evolutionarily conserved nucleotide within a transcription factor-binding site. A second mutation, IVS1+1G>C, is at the donor splice site of the first exon. In vitro electrophoretic mobility shift assays show a decrease in nuclear extract-protein binding at the g.−132G>A mutant site. The promoter mutation results in decreased transcription using luciferase reporter plasmids. Analysis of cDNA from cells transfected with plasmids harboring the IVS1+1G>C mutation results in aberrant splicing leading to complete retention of the first intron (~5 kb). The IVS1+1G>C splicing mutation results in loss of luciferase activity from a reporter plasmid. These novel mutations in ALDOB represent 2% of alleles in American HFI patients, with IVS1+1G>C representing a significantly higher allele frequency (6%) among HFI patients of Hispanic and African-American ethnicity.
Appendix
Available only for authorised users
Literature
go back to reference Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with image. J Biophoton Int 11:36–42 Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with image. J Biophoton Int 11:36–42
go back to reference Ali M, Tunçman G, Cross N et al (1994) Null alleles of the aldolase B gene in patients with hereditary fructose intolerance. J Med Genet 31:499–503CrossRefPubMed Ali M, Tunçman G, Cross N et al (1994) Null alleles of the aldolase B gene in patients with hereditary fructose intolerance. J Med Genet 31:499–503CrossRefPubMed
go back to reference Ali M, James CL, Cox TM (1996) A newly identified aldolase B splicing mutation (G– > C, 5′ intron 5) in hereditary fructose intolerance from New Zealand. Hum Mutat 7:155–157CrossRefPubMed Ali M, James CL, Cox TM (1996) A newly identified aldolase B splicing mutation (G– > C, 5′ intron 5) in hereditary fructose intolerance from New Zealand. Hum Mutat 7:155–157CrossRefPubMed
go back to reference Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarumsay N (1978) Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Helv Paediatr Acta 33:465–487PubMed Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarumsay N (1978) Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Helv Paediatr Acta 33:465–487PubMed
go back to reference Berardini T, Amsden AB, Penhoet EE, Tolan DR (1999) Identification of conserved promoter elements for aldB and isozyme specific residues in aldolase B. Comp Biochem Physiol 122:53–61 Berardini T, Amsden AB, Penhoet EE, Tolan DR (1999) Identification of conserved promoter elements for aldB and isozyme specific residues in aldolase B. Comp Biochem Physiol 122:53–61
go back to reference Brooks CC, Buist N, Tuerck J, Tolan DR (1991) Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance. Am J Hum Genet 49:1075–1081PubMed Brooks CC, Buist N, Tuerck J, Tolan DR (1991) Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance. Am J Hum Genet 49:1075–1081PubMed
go back to reference Coffee EM, Yerkes L, Ewen EP, Zee T, Tolan DR (2009) Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population. J Inherit Metab Dis 33:33–42CrossRefPubMed Coffee EM, Yerkes L, Ewen EP, Zee T, Tolan DR (2009) Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population. J Inherit Metab Dis 33:33–42CrossRefPubMed
go back to reference Cox TM (1988) Hereditary fructose intolerance. Quart J Med 68:585–594PubMed Cox TM (1988) Hereditary fructose intolerance. Quart J Med 68:585–594PubMed
go back to reference Cox TM (1993) Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child 69:423–415CrossRef Cox TM (1993) Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child 69:423–415CrossRef
go back to reference Cross NC, Cox TM (1990) Partial aldolase B gene deletions in hereditary fructose intolerance. Am J Hum Genet 47:101–106PubMed Cross NC, Cox TM (1990) Partial aldolase B gene deletions in hereditary fructose intolerance. Am J Hum Genet 47:101–106PubMed
go back to reference Crossley M, Brownlee GG (1990) Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 345:444–446CrossRefPubMed Crossley M, Brownlee GG (1990) Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 345:444–446CrossRefPubMed
go back to reference Doyle SA, Tolan DR (1995) Characterization of recombinant human aldolase B and purification by metal chelate chromatography. Biochem Biophys Res Commun 206:902–908CrossRefPubMed Doyle SA, Tolan DR (1995) Characterization of recombinant human aldolase B and purification by metal chelate chromatography. Biochem Biophys Res Commun 206:902–908CrossRefPubMed
go back to reference Esposito G, Santamaria R, Vitagliano L et al (2004) Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene. Hum Mutat 24:534CrossRefPubMed Esposito G, Santamaria R, Vitagliano L et al (2004) Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene. Hum Mutat 24:534CrossRefPubMed
go back to reference Froesch ER, Wolf HP, Baitsch H, Prader A, Labhart A (1963) Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase. Am J Med 34:151–167CrossRefPubMed Froesch ER, Wolf HP, Baitsch H, Prader A, Labhart A (1963) Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase. Am J Med 34:151–167CrossRefPubMed
go back to reference Funari VA, Voevodski K, Leyfer D, Yerkes K, Cramer D, Tolan DR (2010) Quantitative gene-expression profiles in real time from expressed sequence tag database. Gene Expr 14:321–336CrossRefPubMed Funari VA, Voevodski K, Leyfer D, Yerkes K, Cramer D, Tolan DR (2010) Quantitative gene-expression profiles in real time from expressed sequence tag database. Gene Expr 14:321–336CrossRefPubMed
go back to reference Gitzelmann R, Baerlocher K (1973) Vorteile und Nachteile der Frucosein der Nahrung. Padiatr Fortbildungsk Prax 37:40–55 Gitzelmann R, Baerlocher K (1973) Vorteile und Nachteile der Frucosein der Nahrung. Padiatr Fortbildungsk Prax 37:40–55
go back to reference Gregori C, Ginot F, Decaux J-F et al (1991) Expression of the rat aldolase B gene: a liver-specific proximal promoter and an intronic activator. Biochem Biophys Res Commun 176:722–729CrossRefPubMed Gregori C, Ginot F, Decaux J-F et al (1991) Expression of the rat aldolase B gene: a liver-specific proximal promoter and an intronic activator. Biochem Biophys Res Commun 176:722–729CrossRefPubMed
go back to reference Gregori C, Kahn A, Pichard AL (1993) Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. Nucleic Acids Res 21:897–903CrossRefPubMed Gregori C, Kahn A, Pichard AL (1993) Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. Nucleic Acids Res 21:897–903CrossRefPubMed
go back to reference Gregori C, Kahn A, Pichard AL (1994) Activity of the rat liver-specific aldolase B promoter is restrained by HNF3. Nucleic Acids Res 22:1242–1246CrossRefPubMed Gregori C, Kahn A, Pichard AL (1994) Activity of the rat liver-specific aldolase B promoter is restrained by HNF3. Nucleic Acids Res 22:1242–1246CrossRefPubMed
go back to reference Gregori C, Porteu A, Lopez S, Kahn A, Pichard AL (1998) Characterization of the aldolase B intronic enhancer. J Biol Chem 273:25237–25243CrossRefPubMed Gregori C, Porteu A, Lopez S, Kahn A, Pichard AL (1998) Characterization of the aldolase B intronic enhancer. J Biol Chem 273:25237–25243CrossRefPubMed
go back to reference Hers H-G, Joassin G (1961) Anomalie de l’aldolase hepatique dans l’intolerance au fructose. Enzymol Biol Clin 1:4–14 Hers H-G, Joassin G (1961) Anomalie de l’aldolase hepatique dans l’intolerance au fructose. Enzymol Biol Clin 1:4–14
go back to reference James CL, Rellos P, Ali M, Heeley AF, Cox TM (1996) Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population. J Med Genet 33:837–841CrossRefPubMed James CL, Rellos P, Ali M, Heeley AF, Cox TM (1996) Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population. J Med Genet 33:837–841CrossRefPubMed
go back to reference Koivisto UM, Palvimo JJ, Janne OA, Kontula K (1994) A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 91:10526–10530CrossRefPubMed Koivisto UM, Palvimo JJ, Janne OA, Kontula K (1994) A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 91:10526–10530CrossRefPubMed
go back to reference Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54CrossRefPubMed Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54CrossRefPubMed
go back to reference Laméire N, Mussche M, Baele G, Kint J, Ringoir S (1978) Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med 65:416–423CrossRefPubMed Laméire N, Mussche M, Baele G, Kint J, Ringoir S (1978) Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med 65:416–423CrossRefPubMed
go back to reference Lopez-Lastra M, Rivas A, Barria MI (2005) Protein synthesis in eukaryotes: the growing biological relevance of cap-independent translation initiation. Biol Res 38:121–146CrossRefPubMed Lopez-Lastra M, Rivas A, Barria MI (2005) Protein synthesis in eukaryotes: the growing biological relevance of cap-independent translation initiation. Biol Res 38:121–146CrossRefPubMed
go back to reference Malay AD, Procious SL, Tolan DR (2002) The temperature dependence of activity and structure for the most prevalent mutant aldolase B associated with hereditary fructose intolerance. Arch Biochem Biophys 408:295–304CrossRefPubMed Malay AD, Procious SL, Tolan DR (2002) The temperature dependence of activity and structure for the most prevalent mutant aldolase B associated with hereditary fructose intolerance. Arch Biochem Biophys 408:295–304CrossRefPubMed
go back to reference McGlincy NJ, Smith CW (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci 33:385–393CrossRefPubMed McGlincy NJ, Smith CW (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci 33:385–393CrossRefPubMed
go back to reference Morris RCJ (1968) An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis: its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest 47:1648–1663PubMed Morris RCJ (1968) An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis: its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest 47:1648–1663PubMed
go back to reference Odièvre M, Gentil C, Gautier M, Alagille D (1978) Hereditary fructose intolerance in childhood: diagnosis, management and course in 55 patients. Am J Dis Child 132:605–608PubMed Odièvre M, Gentil C, Gautier M, Alagille D (1978) Hereditary fructose intolerance in childhood: diagnosis, management and course in 55 patients. Am J Dis Child 132:605–608PubMed
go back to reference Orkin SH, Alter BP, Altay C et al (1978) Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. New Engl J Med 299:166–172CrossRefPubMed Orkin SH, Alter BP, Altay C et al (1978) Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. New Engl J Med 299:166–172CrossRefPubMed
go back to reference Park HD, Kim YK, Park KU, Kim JQ, Song YH, Song J (2009) A novel c.-22 T > C mutation in GALK1 promoter is associated with elevated galactokinase phenotype. BMC Med Genet 10:29CrossRefPubMed Park HD, Kim YK, Park KU, Kim JQ, Song YH, Song J (2009) A novel c.-22 T > C mutation in GALK1 promoter is associated with elevated galactokinase phenotype. BMC Med Genet 10:29CrossRefPubMed
go back to reference Perez-Tur J, Froelich S, Prihar G et al (1995) A mutation in Alzheimer’s disease destroying a splice acceptor site in the presenilin-1 gene. NeuroReport 7:297–301PubMed Perez-Tur J, Froelich S, Prihar G et al (1995) A mutation in Alzheimer’s disease destroying a splice acceptor site in the presenilin-1 gene. NeuroReport 7:297–301PubMed
go back to reference Raymondjean M, Pichard A-L, Gregori C, Ginot F, Kahn A (1991) Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter. Nucleic Acids Res 19:6145–6153CrossRefPubMed Raymondjean M, Pichard A-L, Gregori C, Ginot F, Kahn A (1991) Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter. Nucleic Acids Res 19:6145–6153CrossRefPubMed
go back to reference Saiki RK, Scharf S, Faloona F et al (1985) Enzymatic amplification of b-globin genomic sequences and restriction analysis for diagnosis of sickle cell anemia. Science 230:1350–1354CrossRefPubMed Saiki RK, Scharf S, Faloona F et al (1985) Enzymatic amplification of b-globin genomic sequences and restriction analysis for diagnosis of sickle cell anemia. Science 230:1350–1354CrossRefPubMed
go back to reference Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP (1991) Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 353:83–86CrossRefPubMed Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP (1991) Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 353:83–86CrossRefPubMed
go back to reference Santer R, Rischewski J, von Weihe M et al (2005) The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Hum Mutat 25:594CrossRefPubMed Santer R, Rischewski J, von Weihe M et al (2005) The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Hum Mutat 25:594CrossRefPubMed
go back to reference Silva al. Romao L (2009) The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! which players make the decision? FEBS Lett 583:499–505CrossRefPubMed Silva al. Romao L (2009) The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! which players make the decision? FEBS Lett 583:499–505CrossRefPubMed
go back to reference Steinmann B, Gitzelmann R (1981) The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta 36:297–316PubMed Steinmann B, Gitzelmann R (1981) The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta 36:297–316PubMed
go back to reference Steinmann B, Gitzelmann R, Van den Berghe G (2001) Disorders of fructose metabolism. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1489–1520 Steinmann B, Gitzelmann R, Van den Berghe G (2001) Disorders of fructose metabolism. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1489–1520
go back to reference Tolan DR, Brooks CC (1992) Molecular analysis of common aldolase B alleles for hereditary fructose intolerance in North Americans. Biochem Mol Med 48:19–25 Tolan DR, Brooks CC (1992) Molecular analysis of common aldolase B alleles for hereditary fructose intolerance in North Americans. Biochem Mol Med 48:19–25
go back to reference Tolan DR, Penhoet EE (1986) Characterization of the human aldolase B gene. Mol Biol Med 3:245–264PubMed Tolan DR, Penhoet EE (1986) Characterization of the human aldolase B gene. Mol Biol Med 3:245–264PubMed
go back to reference Tsutsumi K, Ito K, Ishikawa K (1989) Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene. Mol Cell Biol 9:4923–4931PubMed Tsutsumi K, Ito K, Ishikawa K (1989) Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene. Mol Cell Biol 9:4923–4931PubMed
go back to reference Vallet V, Bens M, Antoine B et al (1995) Transcription factors and aldolase B gene expression in microdissected renal proximal tubules and derived cell lines. Exp Cell Res 216:363–370CrossRefPubMed Vallet V, Bens M, Antoine B et al (1995) Transcription factors and aldolase B gene expression in microdissected renal proximal tubules and derived cell lines. Exp Cell Res 216:363–370CrossRefPubMed
go back to reference Yabuki T, Ejiri S, Tsutsumi K (1993) Ubiquitous factors that interact simultaneously with two distinct cis-elements on the rat aldolase B gene promoter. Biochim Biophys Acta 1216:15–19PubMed Yabuki T, Ejiri S, Tsutsumi K (1993) Ubiquitous factors that interact simultaneously with two distinct cis-elements on the rat aldolase B gene promoter. Biochim Biophys Acta 1216:15–19PubMed
Metadata
Title
Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance
Authors
Erin M. Coffee
Dean R. Tolan
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9192-5

Other articles of this Issue 6/2010

Journal of Inherited Metabolic Disease 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine